期刊文献+

中心复合设计法优化盐酸伪麻黄碱缓释微丸包衣液处方 被引量:2

Optimization of coating solution formulation of pseudoephedrine hydrochloride sustained-release pellets by a central composite design
下载PDF
导出
摘要 目的:采用Eudragit RS30D对盐酸伪麻黄碱微丸进行缓释包衣,优化包衣液处方。方法:通过单因素考察,确定影响药物释放的主要因素,以综合评分值(Y)为评价指标,采用中心复合设计试验对包衣液处方进行优化,确立处方组成,并在优化区域内选择一点安排一次验证试验,以检验优化工艺条件的有效性。结果:理论包衣增重(X1)和抗黏剂滑石粉用量(X2)是影响药物释放的主要因素,其中理论包衣增重(X1)对评价指标有非常显著影响(P<0.01),拟合所得多元二次方程为Y=576.2-17.88X1-4.244X2+0.1449X12+0.06391X1X2+0.01080X22,r=0.9775。验证试验表明,本优化方程有良好的预测性。结论:中心复合设计法优化的制备条件良好,制得的盐酸伪麻黄碱缓释微丸的体外累积释放度符合要求。 Objective :To optimize coating solution formulation using Eudragit RS30D and prepare pseudoephedrine hydrochloride sustained-release pellets. Methods:The formulation was developed based on a single-factor test, which was carried out to screen the critical influencing factors for the release rate. The optimal formulations were obtained by a central composite design. Results:The theoretical increment in coating weight (X1) and the anti-adhesive agent talc (X2 ) were the main factors which influenced the release rate. Among the two materials, the theoretical increment in coating weight (X1) affected the release rate more dramatically (P 〈 0.01 ). The correlation equation was Y = 576.2 - 17.88X1 - 4. 244X2 + 0. 144 9X21 + 0. 063 91X1X2 + 0. 010 80X22 and the correlation coefficient was 0. 977 5. Validation results showed that this equation was capable of prediction for optimization of the formulation. Conclusion :The central composite design was able to optimize the coating solution formulation of pseudoephedrine hydrochloride sustained-release pellets.
出处 《中国新药杂志》 CAS CSCD 北大核心 2007年第16期1275-1279,共5页 Chinese Journal of New Drugs
关键词 中心复合设计 盐酸伪麻黄碱 缓释微丸 丙烯酸树脂 central composite design pseudoephedrine hydrochloride sustained-release pellets Eudragit RS30D
  • 相关文献

参考文献7

二级参考文献33

  • 1张述禹,俞腾飞,赵燕霞,田朝晖,高志岩.麻黄碱对离体大鼠肛尾肌及门静脉的作用[J].内蒙古医学院学报,1994,16(2):100-103. 被引量:3
  • 2朱明晏 赵乃才.麻黄碱对兔肺动脉条的作用机理[J].中国药理学与毒理学杂志,1987,1(4):254-257.
  • 3贡沁燕 杨藻宸.麻黄碱对兔主动脉和心房作用机制的研究[J].生理学报,1984,36(4):367-373.
  • 4何端生.麻黄素百年话[J].药学通报,1986,21(8):488-491.
  • 5Trendelenbury U,Gomez Alonso dela Sierre B,Muskus A.Modification by reserpine of the response of the atrial pacemaker to sympathomimetic amines[J].J Pharmacol Exp Ther,1963,141:301-309.
  • 6Moore J I,Moran NC.Cardiac contractile force response to ephedrine and other sympathomimetic amines in dogs after pretreatment with reserpine[J].J.Pharmacol Exp Ther 1962,136(1):89-96.
  • 7Waldeck B,Widmark E.The interaction of ephedrine with β-adrenoceptors in tracheal,cardiac and skeletal muscles[J].Clin Exp Pharm Physio,1985,12:439-442.
  • 8Morishita H,Furnkawa T.The vascular changes after ephedrine tachyphylaxis[J].J Pharm Pharmacol,1975,27:574-579.
  • 9Caldwell R W,Goldberg L I.An evaluation of the vasodilation produced by mephentermine and certain other sympathomimetic amines[J].J Pharmacol Exp Ther 1970,172(2):389-396.
  • 10Grandy J L,Hodgson D S,Dunlop C I,et al.Cardiopulmonary effects of ephedrine in halothane-anesthetized horses[J].J Vet Pharmacol Ther,1989,12(4):389-396.

共引文献72

同被引文献15

  • 1黎芸,程一帆,古碧秀.三七总皂苷制剂的临床应用近况[J].中国药业,2006,15(6):57-58. 被引量:15
  • 2陈丽华,冯怡,徐德生.中药缓控释微丸制剂的研究进展[J].中国中药杂志,2007,32(6):472-475. 被引量:21
  • 3Hamed E, Sakr A. Application of multiple response optimization technique to extended release formulations design [ J ]. J Controlled Release, 2001,73:326.
  • 4中国药典.一部[S].2005:223.
  • 5PRADHAN S C, GIRISH C. Hepatoprotective herbal drug,silymarin from experimental pharmacology to clinical medicine[J].Indian J Med Res ,2006,124(5 ) :491-504.
  • 6YANYU X,YUNMEI S,ZHIPENG C,et al. The preparation of silybin - phospholipid complex and the study on its pharmacokinetics in rats [ J ]. Int J Pharm, 2006,307 ( 1 ) : 77 -82.
  • 7MARIAGRAZIA M, CERT R, BERNT N, et al. Osmotic pu- mping release from ethyl- hydroxypropyl-cellulose-coated pellets:a new mechanistic model [ J ]. J Control Release, 2010,142:53-60.
  • 8JI B,WANG D, XUE M Y, et al. Preparation of metformin hydrochlorrode pellets by using a centrifugal granulator[J].Chin Hosp Pharm J,2006,26 ( 3 ) : 292-294.
  • 9SAUER D, MCGINITY J. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100- 55 [J].Pharm Dev Techno, 2009,14 ( 6 ) : 632-641.
  • 10李小芳,汤贯光,邱爽.中药微丸制备工艺研究进展[J].中成药,2009,31(3):450-452. 被引量:10

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部